InMode said it received a full, unconditional buyout offer from a group of investors led by cofounder and CEO Moshe Mizrahi. The bid, submitted through M.N. Business Strategy Ltd. and related entities connected to Mizrahi, seeks to buy all shares not already held by the group for cash at $16.20 per share. That price is about 21% above Tuesday’s closing price of $13.35 and implies a total equity value of roughly $1.026 billion based on 63.36 million outstanding shares.
The stock jumped about 11% at the open in New York after the announcement. InMode noted this is not the first attempt to take the Israeli medical aesthetics company off the U.S. market. In early 2026, it ran a sale process led by Bank of America, during which higher offers were made that valued the company at about $1.1 billion.
One proposal came from Mizrahi, then in partnership with Maier Shamir of Mivtach Shamir. Another came from South Korean private equity firm Centroid, and a third from U.S. firm Steel Partners, which offered to buy 51% of the company at $18 a share, or about $1.13 billion. In February 2026, an independent board committee rejected all three offers, saying that “none of them is sufficient and does not serve the interests of the company and its shareholders,” and the process was formally halted.
Since then, the share price has remained weak amid negative sentiment and some erosion in profitability in recent quarters, despite first-quarter revenue growth and a strong cash position. Mizrahi now owns about 7% of the company directly after buying roughly $10 million of stock around April. InMode said the board received the new offer on June 17 and immediately formed a special committee of only independent directors to review it with financial and legal advisers. The company said it will not provide further updates unless required by law.
